Inventor
PATRICK RENE ANGIBAUD
Inventor
FR
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds37%
A61KPreparations for medical, dental or toiletry purposes26%
PatentTitleYear
12,084,462Spiro bicyclic inhibitors of menin-MLL interaction202411,542,247Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment of cancer202311,530,226Azepane inhibitors of menin-MLL interaction202211,396,517Exo-aza spiro inhibitors of menin-MLL interaction202211,267,804(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity202211,220,517Spiro bicyclic inhibitors of menin-MLL interaction202211,155,555Compounds2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to JANSSEN PHARMACEUTICA NV (7)· patent assignee history
2021–2024Based in FR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICA NV | 7 | 2021–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| FR | 7 | 2021–2024 |